Genetic variations in dysbindin-1 (dystrobrevin-binding protein-1) are one of the most commonly reported variations associated with schizophrenia. As schizophrenia could be regarded as a neurodevelopmental disorder resulting from abnormalities of synaptic connectivity, we attempted to clarify the function of dysbindin-1 in neuronal development. We examined the developmental change of dysbindin-1 in rat brain by western blotting and found that a 50 kDa isoform is highly expressed during the embryonic stage, whereas a 40 kDa one is detected at postnatal day 11 and increased thereafter. Immunofluorescent analyses revealed that dysbindin-1 is enriched at the spine-like structure of primary cultured rat hippocampal neurons. We identified WAVE2, but not N-WASP, as a binding partner for dysbindin-1. We also found that Abi-1, a binding molecule for WAVE2 involved in spine morphogenesis, interacts with dysbindin-1. Although dysbindin-1, WAVE2 and Abi-1 form a ternary complex, dysbindin-1 promoted the binding of WAVE2 to Abi-1. RNA interference-mediated knockdown of dysbindin-1 led to the generation of abnormally elongated immature dendritic protrusions. The present results indicate possible functions of dysbindin-1 at the postsynapse in the regulation of dendritic spine morphogenesis through the interaction with WAVE2 and Abi-1. Molecular Psychiatry (2010) 15, 976-986;
Introduction
Schizophrenia is a severe mental disorder featured by various psychotic phenomena such as hallucinations and delusions. 1 Genetic factors are known to be important in the etiology of schizophrenia and several susceptible genes such as disrupted-in-schizophrenia-1, neuregulin, Akt and dysbindin-1 have been identified in linkage or association studies. [1] [2] [3] [4] Although the pathophysiology is yet to be determined, unusual neurotransmissions such as dopaminergic and glutamatergic systems have been suggested for the mechanism of schizophrenia symptoms. 1 On the other hand, a concept that schizophrenia is a neurite malformation illness has been arisen based on the observations that disrupted-in-schizophrenia-1 is involved in neuronal development. [5] [6] [7] The gene for dysbindin-1 is situated at chromosome 6, the location of one of the most established linkages to schizophrenia. [8] [9] [10] After an initial report of genetic association between dysbindin-1 gene (dystrobrevinbinding protein-1) and schizophrenia, 11 significant haplotypic associations have been found by several other groups in independent populations of schizophrenic cases. [12] [13] [14] [15] [16] [17] [18] In addition, reduction of the gene 19 and the protein 20 of dysbindin-1 has been reported in brain from schizophrenic cases. Hence, genetic variations in the dysbindin-1 gene might be a major risk factor for schizophrenia. Dysbindin-1 was first identified as a binding partner for dystrobrevin, a component of the dystrophin-associated protein complex 21 located at membranes of muscle. 22 The dystrophin complex and dysbindin-1 were also found at neuronal pre-and postsynapses, [23] [24] [25] [26] suggesting physiological functions there. Indeed, silencing of dysbindin-1 in neurons by RNA interference alters glutamate and dopamine release, 18, 27 whereas the function of dysbindin-1 in the dopamine D 2 receptor internalization has been reported. 28 In addition, snapin, an interacting molecule of synaptosomeassociated protein of 25 kDa, has been identified as a binding partner for dysbindin-1. 26 These results, as well as the phenotypes of dysbindin-1-deficient sandy mice in neurosecretion, 29 suggest that dysbindin-1 participates in neurotransmitter release. On the other hand, dysbindin-1 has been linked to the phosphatidylinositol 3-kinase-Akt signaling, as decreased dysbindin-1 level in cultured neurons attenuated Akt signaling and consequently increased neuronal death, 18 indicating functions of dysbindin-1 in signal transduction pathways in neurons. Recently, the function of the dysbindin-1-containing complex, biogenesis of lysosome-related organelles complex, in neurite growth has been shown. 30 Rho family GTPases are known for their effects on actin cytoskeleton. 31 Of the family members, RhoA, Rac and Cdc42 have been characterized extensively. In fibroblasts, activation of RhoA, Rac and Cdc42 leads to reorganization of actin cytoskeleton into distinct structures: stress fibers, lamellipodia and filopodia, respectively. 31 In neurons, Rho GTPases and related molecules have important functions in dendritic morphogenesis 32 because the cytoskeleton of mature dendritic protrusions named spines and immature protrusions named filopodia is largely actin based. 33, 34 There are several reports describing participation of Rac/Cdc42 and their effectors in dendritic morphogenesis. Insulin receptor substrate 53 (IRSp53), an effector protein that couples activated Rac/Cdc42 to actin cytoskeleton, is known to participate in the regulation of dendritic morphogenesis. 35 Rac binds to the N-terminal Rac-binding domain (RCB) of IRSp53, and the C-terminal SH3 domain of IRSp53 binds to WAVE2 (Wiskott-Aldrich syndrome protein family Verprolin-homologous protein 2), a member of the WAVE family. 36 Recently, abelson interacting protein-1 (Abi-1), an interacting partner for WAVE2, has also been shown to be essential for dendritic morphogenesis. 37 In this study, we characterized the feature of dysbindin-1 in rat neuronal tissues. We then identified WAVE2 and its interacting molecule, Abi-1, as binding partners for dysbindin-1. Interestingly, expression of WAVE2 and Abi-1, and their complex formation was affected by dysbindin-1. Knockdown of dysbindin-1 in primary cultured rat hippocampal neurons caused increase of abnormally elongated immature dendritic protrusions, which was rescued by RNAi-resistant dysbindin-1. These results strongly suggest that dysbindin-1 regulates dendritic morphogenesis in developing neurons coordinately with WAVE2 and Abi-1. The results obtained in this study also may support the neurodevelopmental hypothesis of schizophrenia that abnormal neurite/spine formation is a possible pathophysiology of the disease.
Materials and methods
Information about plasmid construction, RNA interference, antibodies, cell culture, transfection, preparation of rat tissue extracts and western blotting is provided in Supplementary Information.
Morphological studies
Rat was deeply anesthetized with pentobarbital (100 mg kg -1 , i.p.) and perfused transcardially with saline followed by 4% paraformaldehyde and 0.2% picric acid in 0.1 M phosphate buffer (pH 7.4). The fixed brains were embedded in paraffin, and saggital sections (6 mm thickness, 1 to 2 mm from midline) and coronal sections of cerebrum (6 mm thickness, À3.7 to À4.2 mm from bregma) and cerebellum (6 mm thickness, À10.3 to À11.3 mm from bregma) were prepared.
After deparaffinization, sections were processed for immunohistochemistry as reported earlier. 38 Images were obtained using BX61 microscope with an attached DP-70 digital camera (Olympus, Tokyo, Japan). Immunofluorescent analysis was performed as described. 39 Alexa Fluor 488 and 568 (Invitrogen, Carlsbad, CA, USA) were used as secondary antibodies. Fluorescent images were obtained using a FLUOVIEW confocal microscope (Olympus).
Immunoprecipitation Immunoprecipitation was performed as described. 40 Briefly, cells or rat brain extracts were prepared with lysis buffer containing 50 mM Tris-HCl (pH 8.0), 150 mM NaCl, 1% Nonidet P-40 and protease inhibitor cocktail (Sigma-Aldrich, St Louis, MO, USA). After centrifugation at 4 1C for 10 min at 10 000 g, Nonidet P-40-soluble fractions, but not insoluble ones, were subjected to immunoprecipitation using anti-dysbindin-1, anti-Abi-1 or anti-GFP. After washing the beads three times with the lysis buffer, precipitates were subjected to SDS-PAGE (10% gel) followed by western blotting as described. 41 In some experiments, relative intensities of bands were quantified with ImagePro PLUS software (Media Cybernetics, Silver Spring, MD, USA) based on densitometry and expressed as relative intensities to control group.
In vitro binding assay Purified
His-WAVE-homology domain (WHD) (100 pmol) or His-Abi-1 (100 pmol) was incubated with MBP (400 pmol) or MBP-dysbindin-1 (400 pmol) in incubation buffer containing 50 mM Tris-HCl (pH 8.0), 150 mM NaCl, 1% Nonidet P-40 and protease inhibitor cocktail at 4 1C for 1 h. After incubation, Ni-NTA agarose (Qiagen, Hilden, Germany) preequilibrated with the incubation buffer was added and incubated at 4 1C for 1 h. Agarose was then pelleted by centrifugation and washed three times with the incubation buffer. Bound proteins were subjected to SDS-PAGE followed by western blotting.
Quantitative analysis of spine morphologies Transfected neurons were visualized by immunostaining of co-transfected GFP (pbact-EGFP, kindly provided by Dr S Okabe, University of Tokyo) 42 with polyclonal anti-GFP. Transfected cells were chosen randomly and images were obtained using a FLUOVIEW confocal microscope. 43, 44 We usually took 0.5 mm z series stacks and used the FLUOVIEW software to generate image projections for quantitative analyses. Morphometric measurements were performed using ImagePro PLUS software. To analyze spine morphology, 200-350 spines (from 15-30 neurons) were measured for each condition. For the analyses of spine density, spines were defined as 0.5-6 mm lengths, with or without a head, and measured by counting the number of protrusions at 20 mm of primary dendrites. For spine length, distance from the base of neck to the spine head was measured.
Spine densities and lengths were first averaged per neuron and means from multiple individual neurons were calculated. Morphological assessments of spine density, length and shape were conducted blindly. Definitions of spine group were according to earlier reports. 45, 46 Statistical analyses Statistical analyses were performed by the two-tailed multiple t-test with Bonferroni's correction.
Results
Characterization of dysbindin-1 in rat neuronal tissues To explore the physiological significance of dysbindin-1 in neuronal tissues, we developed a rabbit polyclonal antibody against dysbindin-1 (antidysbindin-1). The antibody recognized endogenous and exogenous dysbindin-1 in mammalian cell lines and/or rat brain (Supplementary Figures S1a,  b and S2a, c). The specificity of the antibody was confirmed by the preabsorption of the antibody with excess amount of the antigen, and RNA interference experiments (Supplementary Figures S1a, c and S2b, d). With the antibody, we determined the tissue distribution of dysbindin-1 in adult rat by western blotting. The band with a molecular mass of B50 kDa was clearly detected in cerebrum, cerebellum, lung, adrenal gland, uterus, ovary and testis (Figure 1a) . Consistent with earlier reports, 20 the band with B40 kDa was detected only in cerebrum and cerebellum. In addition, B46 kDa protein was detected in cerebellum, small intestine and testis. This protein is possible to be a tissue-specific isoform, although the possibility cannot be ruled out that it was a degradation product of the 50 kDa protein. We then analyzed the expression pattern in 12 brain regions and found that olfactory bulb contains a major 50 kDa band, whereas hypothalamus, septum, striatum, hippocampus and enthorhinal cortex mainly contain a 40 kDa band ( Figure 1b) . We then determined expression profile of dysbindin-1 in rat brain during embryonic (a) Distribution of dysbindin-1 in rat tissues. Cytosolic fractions (20 mg of protein) from adult rat organs were separated by SDS-PAGE (10% gel) followed by western blotting using anti-dysbindin-1. EDL, extensor degitorum longus muscle. (b) Regional expression of dysbindin-1 in the brain. Various brain regions were dissected from adult rat and whole tissue extracts were prepared with 2% SDS-containing buffer. Each extract (20 mg of protein) was subjected to SDS-PAGE (10% gel) followed by western blotting using anti-dysnindin-1 (DYSB) and anti-synaptophysin (SYP). (c) Developmental changes of dysbindin-1 expression in the brain. Whole brain lysates at various developmental stages were subjected to SDS-PAGE (10% gel, 20 mg of protein) followed by western blotting using anti-dysbindin-1. The developmental process was confirmed with a glial cell differentiation marker GFAP. (d) Subcellular localization of dysbindin-1 in the brain. Equal aliquots of subcellular fractions (20 mg of protein for dysbindin-1 and 5 mg for synaptophysin and PSD-95) were subjected to western blotting using anti-dysbindin-1, antisynaptophysin and anti-PSD-95. The arrow and arrowhead indicate dysbindin-1 and its possible degradation form, respectively. (e, f, g) Localization of dysbindin-1 in primary cultured hippocampal neurons. Neurons at 3 div (e) and 28 div (f, g) were double stained for dysbindin-1 with Tau-1 (e), synaptophysin (f) or PSD-95 (g). Images of the indicated areas in upper panels of (f) and (g) are magnified in lower panels. Merged signals are indicated with arrows. Bars, 50 mm (e and upper panels of f and g), 5 mm (lower panels of f and g).
Dysbindin-1 controls spine morphogenesis
H Ito et al and postnatal development. The 50 kDa band was strongly detected in embryonic stages, whereas the protein level decreased at P0 and unchanged thereafter ( Figure 1c ). In contrast, the 40 kDa band was barely detected in embryonic brain, but tended to increase after P11 ( Figure 1c ). Subcellular fractionation of rat brain showed that dysbindin-1 with B50 kDa was found in synaptosome and PSD fractions (Figure 1d , arrow). The B48 kDa band may be a degradation product of dysbindin-1 (Figure 1d , arrowhead).
Immunohistochemical analyses revealed dysbindin-1 enrichment in dendrites and soma of neurons in rat cerebral cortex and hippocampus (Supplementary Figure S2a ). In cerebellum, immunoreactivity was detected in dendrites and soma of Purkinje cells, but the function of dysbindin-1 in the cell remains to be clarified (Supplementary Figure S2c) . Preabsorption of anti-dysbindin-1 with excess amount of the antigen caused marked reduction of immunoreactivity in cerebrum and cerebellum (Supplementary Figure S2b and d) , indicating the specificity of the antibody. On the other hand, immunofluorescent analyses using primary cultured rat hippocampal neurons revealed the localization of dysbindin-1 at soma, axons and dendrites at 3 div (Figure 1e) . In neurons at 28 div, we observed the partial colocalization of dysbindin-1 not only with a presynaptic protein, synaptophysin (Figure 1f ), but also a postsynaptic protein, PSD-95 (Figure 1g ).
Identification of WAVE2 as a binding partner for dysbindin-1
We next tried to identify binding partners for dysbindin-1. First, we searched the online database 'AfCs Yeast 2-Hybrid screen' (http://www.signalinggateway.org/data/Y2H/cgi-bin/y2h.cgi), and found that WAVE2 is a binding partner for dysbindin-1. WAVE2 is a member of the WAVE family composing of WAVE1B3, and has been shown to link activated Rac to actin remodeling through induction of Arp2/3 complex. 47 Participation of WAVE2-related molecules in the generation of dendritic spine has been reported. 35, 48, 49 Owing to the localization at the postsynaptic density of rat brain (Figure 1d ) and matured primary cultured hippocampal neurons (Figure 1g ), dysbindin-1 is likely to be involved in the regulation of spine morphology in cooperation with WAVE2. Thus, we analyzed the interaction of dysbindin-1 with WAVE2, using a kidney cell line, HEK293, which readily expresses exogenous proteins and suitable for immunoprecipitation analyses. We could observe the binding of WAVE2 to dysbindin-1 in the cellular context (Figure 2a) . We then found that other WAVE family members, WAVE1 and WAVE3, also interact with dysbindin-1 (Supplementary Figure  S3) . In contrast, neural Wiskott-Aldrich syndrome protein (N-WASP) did not bind to dysbindin-1 (Figure 2b) , suggestive of the specific interaction of WAVEs with dysbindin-1. Although WAVE1 and WAVE3 are also expressed in neuronal tissues and their possible functions there have been reported, 48, 49 we here focused on WAVE2 as it has been intensively analyzed in terms of the relation with dendritic morphogenesis-related proteins such as Abi-1 and IRSp53. [50] [51] [52] [53] To explore the physiological significance of the binding of WAVE2 to dysbindin-1, we developed an antibody against WAVE2 (Supplementary Figure S4) . When we immunoprecipitated dysbindin-1 from adult rat brain extracts, WAVE2 was detected in the precipitate (Figure 2c ), suggesting that dysbindin-1 and WAVE2 form a physiological complex in the brain. However, the possibility could not be ruled out that not only WAVE2 but also WAVE1 was incorporated in the immunoprecipitate, as the anti-WAVE2 crossreacted with WAVE1 (Supplementary Figure S4d) .
WAVE proteins have characteristic domains such as WHD, basic, proline-rich, verprolin-homology, cofilin-homology and acidic domains. These domains are known to be important for the interaction with other proteins including IRSp53 and Arp2/3 complex. 36 On the other hand, dysbindin-1 has a coiled-coil (CC) domain and a dysbindin domain, the latter of which functional significance remains to be clarified. We carried out mapping analyses to determine domains/regions essential for association between dysbindin-1 and WAVE2. We first determined the region in WAVE2 responsible for the interaction with dysbindin-1. Various GFP-tagged WAVE2 constructs were co-expressed with FLAG-dysbindin-1, and immunoprecipitation was performed using anti-dysbindin-1. As shown in Figure 2d , GFP-WHD, -WHDDC and -WHDN were co-immunoprecipitated with FLAG-dysbindin-1, but GFP-DWHD and -WHDC were not. These results indicate that N-terminus of WHD (aa1-66) interacts with dysbindin-1. Next, to determine the region in dysbindin-1 binding to WAVE2, we co-expressed FLAG-WAVE2 with GFP-dysbindin-N or -C, and immunoprecipitation was performed using anti-GFP. Consequently, dysbindin-N (aa1-177) containing the putative CC domain was found to be crucial for the binding to WAVE2 (Figure 2e) . A CC domain is well accepted to be involved in protein-protein interaction. To determine whether dysbindin-1 binds to WAVE2 directly or indirectly, we attempted to perform in vitro binding experiments using recombinant proteins. We could not obtain recombinant full-length WAVE2 by unknown reason and thus produced recombinant WHD domain (His-WHD), which is responsible for the binding to dysbindin-1. Consequently, we found that dysbindin-1 directly binds to WHD domain of WAVE2 (Figure 2f ).
Dysbindin-1 forms a complex with Abi-1 It has been reported that WAVE2 forms a complex with Abi-1 and the complex mediates membrane protrusions in non-neuronal cells. 54 Abi-1 has also been shown to promote WAVE2 membrane translocation and abelson kinase (Abl)-mediated tyrosine phosphorylation of WAVE2 to induce actin nucleation 50, 52 Interestingly, Abl per se interacts with WAVE2 to induce membrane ruffling and cell spreading in fibroblasts. 50 On the basis of the above observations, we asked whether Abi-1 interacts with dysbindin-1 and found their interaction in HEK293 cells (Figure 3a) . To further analyze the binding of Abi-1 with dysbindin-1, we developed an antibody against Abi-1 (Supplementary Figure S5) .
We could detect the co-immunoprecipitation of Abi-1 with dysbindin-1 from rat brain lysate (Figure 3b ), indicating the physiological interaction of these molecules. We found that dysbindin-1 directly binds to Abi-1 in in vitro binding assays (Figure 3c ).
Abi-1 contains a CC domain and a SH3 domain. As these domains are important for protein-protein interactions, we examined the function of these . Lysates (90 mg of protein) were immunoprecipitated with anti-dysbindin-1. Western blotting of the precipitated materials (IP) and cell lysates (Input) was carried out with anti-FLAG or anti-HA. (c) Co-immunoprecipitation of dysbindin-1 and WAVE2 in adult rat brain. Lysate (1000 mg of protein) was incubated with control IgG or anti-dysbindin-1, and immunoprecipitation was performed followed by western blotting using anti-WAVE2. The lysate (Input, 10 mg protein) was also used as a control. (d, e) Mapping analyses of the interaction between dysbindin-1 and WAVE2. FLAG-dysbindin-1 was expressed with various GFP-tagged mutants of WAVE2 in HEK293 cells (d). Lysates (90 mg of protein) were immunoprecipitated with anti-dysbindin-1. Western blotting of the precipitated materials (IP) and cell lysates (Input) was performed with anti-FLAG or anti-GFP. WHD, WAVE-homology domain; B, basic domain; PR, proline-rich domain; VCA, verprolin-homology, cofilin-homology and acidic domain. (e) FLAG-WAVE2 was expressed with GFP-dysbindin-1, -dysbindin-N or -dysbindin-C in HEK293 cells. Lysates (90 mg of protein) were immunoprecipitated with anti-GFP. Western blotting analyses were performed as in (d). CC, coiled-coil region; DYSB, dysbindin domain. (f) Dysbindin-1 selectively interacts with WHD domain of WAVE2 in vitro. Recombinant His-WHD was incubated with MBP or MBP-dysbindin-1 and then Ni-NTA agarose pre-equilibrated with binding buffer was added. The agarose was washed and bound proteins were subjected to SDS-PAGE followed by western blotting.
domains in the interaction with dysbindin-1. Various GFP-tagged Abi-1 fragments were expressed with myc-dysbindin-1 and immunoprecipitation was performed. As shown in Figure 3d , GFP-CC and GFP-DSH3 were co-sedimented with myc-dysbindin-1, but GFP-DCC and -SH3 were not, indicating that the CC domain in Abi-1 is essential for the binding to dysbindin-1. We also mapped the region in dysbindin-1 responsible for the binding to Abi-1. As shown in Figure 3e , GFP-dysbindin and -dysbindin-center interact with FLAG-Abi-1, whereas GFP-dysbindin-C containing dysbindin (DYSB) domain did not. These results showed that the CC domain of dysbindin-1 is responsible for the interaction to Abi-1. Relatively weak Figure 3 Analyses of the interaction of dysbindin-1 with Abi-1. (a) Immunocomplex formation of dysbindin-1 and Abi-1 in HEK293 cells. FLAG-Abi-1 was expressed with or without FLAG-dysbindin-1 and immunoprecipitaiton was performed using anti-dysbindin-1. Western blotting of precipitated materials (IP) and cell lysates (Input) was performed with anti-FLAG. (b) Dysbindin-1 and Abi-1 form a complex in rat brain. Lysates (500 mg of protein) were incubated with control IgG-or anti-dysbindin-1-conjugated beads and the precipitates were subjected to western blotting using anti-Abi-1. The lysate (10 mg protein) was also used (Input). (c) Dysbindin-1 interacts with Abi-1 in vitro. His-Abi-1 was incubated with MBP or MBP-dysbindin and then Ni-NTA agarose pre-equilibrated with binding buffer was added and incubated. Then the agarose was washed and bound proteins were analyzed by western blotting. (d,e) Mapping analyses of the interaction between dysbindin-1 and Abi-1. Myc-dysbindin-1 was co-expressed with various GFP-tagged fragments of Abi-1 in HEK293 cells (d). Lysates were subjected to immunoprecipitaiton using anti-dysbindin-1. Western blotting of the precipitated materials (IP) and cell lysates (Input) was performed with anti-myc or anti-GFP. FLAG-Abi-1 was co-expressed with GFP-tagged various construct of dysbindin-1 in HEK293 cells (e). Lysates were subjected to immunoprecipitation using anti-Abi-1. Western blotting of the precipitated materials (IP) and cell lysates (Input) was performed with anti-FLAG or anti-GFP. Arrowhead indicates a non-specific band.
interaction of Abi-1 with dysbindin-N and dysbindin (1-210) may be due to conformational change caused by the deletion of the C-terminal portion.
Dysbindin-1 augments the interaction of WAVE2 with Abi-1 Abi-1 is known to form a complex with WAVE2, and we here found the interaction of dysbindin-1 with both Abi-1 and WAVE2. We next examined the effect of dybindin-1 on the complex formation of WAVE2 and Abi-1. FLAG-WAVE2 and myc-Abi-1 were coexpressed with or without FLAG-dysbindin-1 in COS7 cells, and immunoprecipitation was performed using anti-Abi-1. As shown in Figure 4a and b, dysbindin-1 caused increase of the amount of WAVE2 co-immunoprecipitated with Abi-1. As the N-terminus of dysbindin-1 was essential for the binding to WAVE2 (Figure 2e ) and Abi-1 (Figure 3e ), we asked if Figure 4 Dysbindin-1 augments the interaction between WAVE2 and Abi-1. (a) FLAG-WAVE2 and myc-Abi-1 were coexpressed with or without FLAG-dysbindin-1 in COS7 cells. Lysates were subjected to immunoprecipitation using anti-Abi-1. Western blotting of the precipitated materials (IP) and cell lysates (Input) was carried out with anti-FLAG or anti-myc. dysbindin-N is sufficient for the enhancement of WAVE2/Abi-1 complex formation. As shown in Figure 4c and d, dysbindin-N, but not -C, enhanced the binding of WAVE2 to Abi-1 in the cellular context.
We next examined the effect of dysbindn-1 on the WAVE2/Abi-1 complex formation by in vitro binding assays. As we could not produce recombinant fulllength WAVE2, we used WHD domain, a fragment responsible for the binding to Abi-1 and dysbindin-1. First, we performed experiments using His-Abi, His-WHD and MBP-dysbindin-1. As shown in Figure 4e and f, we could not observe the enhancement of His-WHD/His-Abi-1 complex formation by MBP-dysbindin-1 under our experimental conditions. Next, we used myc-WAVE2 (full-length) immunoprecipitated from COS7 cells instead of His-WHD and found that MBPdybindin-1 constantly enhanced the WAVE2/Abi-1 complex formation in vitro (Figure 4g and h) . These results suggest that full-length WAVE2 is required for dysbindin-1-mediated augmentation of WAVE2/Abi-1 complex formation.
Involvement of dysbindin-1 in dendritic morphogenesis of primary cultured rat hippocampal neurons In neuronal tissues, WAVE1/2 and Abi-1 have been shown to have essential functions in dendrite morphogenesis and synapse formation. 35, 37, 49, 55, 56 Therefore, interaction of dysbindin-1 with WAVE2 and Abi-1 implicates a function of dysbindin-1 in the WAVE2-and/or Abi-1-mediated dendritic spine morphogenesis. As dysbindin-1 is co-localized with PSD-95 in matured neurons (Figure 1g) , we examined whether dysbindin-1 is required for the development of dendritic protrusion. To this end, we conducted knockdown of dysbindin-1 in rat hippocampal neurons. We first examined whether pSUPERdysbindin-1#1 silences dysbindin-1. As shown in Figure 5a , the shRNA vector efficiently knocked down myc-tagged rat dysbindin-1 and the observed effects were rescued by RNAi-resistant human dysbindin-1. We next determined whether pSUPER-dysbindin-1#1 silences dysbindin-1 in dissociated rat hippocampal neurons. Neurons at 0 div were transfected with Amaxa Nucleofector device, which resulted in highly efficient gene transfer, and cultured for additional 5 days, and reduction of endogenous dysbindin-1 was confirmed by western blotting (Figure 5b) . Then, we transfected pSUPER-dysbindin-1#1 or control pSU-PER vector with GFP vector in rat hippocampal neurons at 10 div and cultured for 4 additional days. We stained disbindin-1-deficient neurons with anti-GFP because fluorescent intensity of GFP in neurites was not enough for morphological analyses (data not shown). Consequently, dysbindin-1 in dendrites was significantly silenced in neurons transfected with pSUPER-dysbindin-1#1 (Figure 5c and d) . From these results, we concluded that the shRNA vector effectively suppress endogenous dysbindin-1 in rat hippocampal neurons. To clarify the physiological functions of dysbindin-1 in spine morphogenesis, we determined the effect of dysbindin-1 knockdown on the dendritic development. Quantitative analyses revealed that the length was significantly increased in neurons transfected with pSUPER-dysbindin-1#1 (Figure 5e and f) . On the other hand, the density of the protrusion tended to increase by reduction of dysbindin-1, but statistical significance was not observed (Figure 5e and f) . The effect of pSUPER-dysbindin-1#1 on the protrusion length was rescued by RNAiresistant dysbindin-1 (Figure 5e and f) . We further analyzed four established spine morphology groups (that is mushroom spines, stubby spines, thin spines and filopodia, and branched spines) individually (Figure 5g ). Compared with neurons transfected with pSUPER vector, relative percentage of thin spines and filopodia increased and that of mushroom spines concomitantly decreased in neurons transfected with pSUPER-dysbindin-1#1 (Figure 5g ). The effect of the RNAi vector was again rescued by the expression of RNAi-resistant dysbindin-1 (Figure 5g ). We performed the same experiments using pSUPER-dysbindin-1#2, another shRNA for independent target sequence, and confirmed that pSUPER-dysbindin-1#2 also causes impairment of dendritic maturation (Supplementary Figure S6) . It should be noted here that we used fixed cells in the experiments and the obtained results are considered as snapshots at the respective time points because spine structures vary in a matter of hours. 57 We assumed that knockdown of dysbindin-1 may cause reduction of WAVE2/Abi-1 complex in dendritic spines because dysbindin-1 controls WAVE2/ Abi-1 complex formation in cells and in vitro (Figure 4) . To examine the participation of WAVE2/Abi-1 complex in dysbindin-1-mediated spine development, pSUPER-dysbindin-1 was transfected in hippocampal neurons with myc-WAVE2 or myc-Abi-1, and effects of these molecules on spine morphogenesis were analyzed. Consequently, expression of myc-WAVE2 could not rescue the morphological defects induced by knockdown of dysbindin-1 in our experimental conditions (Supplementary Figure S7) . In contrast, myc-Abi-1 tended to rescue the abnormal extension of spine and impairment of spine development (Supplementary Figure S7) . These results suggest that Abi-1 may, at least in part, participate in dysbindin-1-mediated spine morphogenesis.
Discussion
Dendritic spines are protrusions that received the primary excitatory input in the central nervous system. 58, 59 Spine structure is regulated by various molecular mechanisms. 58, 59 Actin filaments provide the main foundation for spine shape, motility and stability. 55 WAVE2 promotes Arp2/3-mediated actin polymerization downstream of Rac. As disruption of IRSp53-WAVE2 interaction decreased both length and density of dendritic protrusions in cultured hippocampal neurons, IRSp53 as well as WAVE2 seems to be involved in dendritic morphogenesis through actin organization. 60 On the other hand, Abi-1 binds to and activates WAVE2 through its phosphorylation, 50, 52 and Abi-1-deficient hippocampal neurons exhibited a high percentage of thin filopodia-like dendritic protrusions. 37 In this study, we clarified that dysbindin-1 interacts with both WAVE2 and Abi-1, and found that silencing of dysbindin-1 causes the phenotype very similar to that observed in Abi-1-deficient hippocampal neurons. On the basis of the result that dysbindin-1 augmented the interaction between WAVE2 and Abi-1, dysbindin-1 may have crucial functions in dendritic maturation through the control of WAVE2/Abi-1 complex formation.
There is no direct evidence indicating that endogenous dysbindin-1 controls WAVE2/Abi-1 complex formation in this study. We tried to clarify whether the knockdown of dysbindin-1 affects the formation of WAVE2/Abi-1 complex in primary cultured rat hippocampal neurons, but could not observe any effects (data not shown). We assume that the amount of dysbindin-1 in hippocampal neurons is relatively less than those of WAVE2 and Abi-1 and, therefore, dysbindin-1 silencing did not affect the complex formation. Indeed, we did semi-quantitative analyses with western blotting and found that contents of WAVE2 (6.97 pmol mg -1 protein) and Abi-1 (9.47 pmol mg -1 protein) were about 50-100 times larger than that of dysbindin-1 (0.15 pmol mg -1 protein). It is possible that dysbindin-1 may regulate WAVE2/Abi-1 complex formation in specific intracellular compartments such as dendritic spines.
Although dysbindin-1 is supposed to be involved in the neurotransmitter release, 18,61 dysbindin-1 distributes at not only pre-but also postsynaptic sides of neurons. 26 In this study, we found that dysbindin-1 is localized at the spine-like structure of primary cultured rat hippocampal neurons, and that reduction of the protein caused abnormal dendritic spine formation, suggestive of involvement of dysbindin-1 in the developmental process of dendrites. It is notable that schizophrenia is now increasingly viewed as a disorder of neurodevelopment. 3, 62 The results obtained in this study imply that deficiency of dysbindin-1 by genetic variations might cause subtle defects in synapse formation during development that may lead to schizophrenia.
It was suggested that disrupted-in-schizophrenia-1 and dysbindin-1 may affect common biological processes including cytoskeletal organization, based on their networks of protein-protein interactions. 63 In this context, disrupted-in-schizophrenia-1 has just recently been reported to participate in the maintenance of spine morphology and function. 64 In conclusion, we found the interaction of dysbindin-1 with WAVE2 and Abi-1, and possible involvement of dysbindin-1 in the dendritic morphogenesis in the neuron. These results might give a new insight to the understanding of schizophrenia pathobiology, although the precise molecular mechanism of the action of dysbindin-1 on the neuronal development remains to be clarified. Further studies are needed to explore the potential diversity of functions played by dysbindin-1 in brain development, neurotransmission and neuroplasticity underlying cognition.
